Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
ROCHE PRODUCTS (NEW ZEALAND) LIMITED,Entrectinib,"Non-small cell lung cancer (NSCLC) - adult patients with ROS1-positive, locally advanced or metastatic",Entrectinib (Rozlytrek),,Community and Hospital,Oncology Agents and Immunosuppressants
